Company Filing History:
Years Active: 2009
Title: Serguei Maliartchouk: Innovator in Apoptosis Research
Introduction
Serguei Maliartchouk is a notable inventor based in San Diego, California. He has made significant contributions to the field of drug discovery, particularly in the area of apoptosis, which is a form of programmed cell death. His innovative work focuses on developing methods that can aid in the treatment of diseases responsive to the induction of apoptosis.
Latest Patents
Maliartchouk holds a patent titled "Methods of treating diseases responsive to induction of apoptosis and screening assays." This invention relates to screening methods that are useful for discovering compounds that induce apoptosis. The methodology specifically targets Apoptosis Inducing Proteins (AIPs) to identify activators that can serve as anticancer agents. The patent outlines various screening methods, including homogenous or heterogeneous binding assays and whole cell assays, which utilize cells with modified levels of AIPs. Additionally, the invention discusses the use of gambogic acid and related compounds for raising antibodies useful in drug discovery.
Career Highlights
Maliartchouk is associated with Cytovia, Inc., where he continues to advance his research in apoptosis and drug discovery. His work is pivotal in the ongoing efforts to develop effective cancer treatments through innovative screening methodologies.
Collaborations
Some of his notable coworkers include Shailaja Kasibhatla and Sui Xiong Cai, who contribute to the collaborative environment at Cytovia, Inc. Their combined expertise enhances the research efforts in the field of apoptosis.
Conclusion
Serguei Maliartchouk's contributions to the field of apoptosis research and drug discovery are significant. His innovative patent and collaboration with esteemed colleagues position him as a key figure in the ongoing fight against cancer.